References
- British Lung Foundation. Available from: https://statistics.blf.org.uk/copd#:~:text=In%20terms%20of%20diagnosed%20cases,suggests%20that%20prevalence%20is%20growing. Accessed 13, 2019.
- SnellN, StrachanD, HubbardR, GibsonJ, Gruffydd-JonesK, JarroldI. S32 Epidemiology of chronic obstructive pulmonary disease (COPD) in the UK: findings from the British lung foundation’s ‘respiratory health of the nation’ project. Thorax. 2016;71(Suppl 3):A20. doi:10.1136/thoraxjnl-2015-207140
- JonesRC, PriceD, RyanD, et al. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med. 2014;2(4):267–276. doi:10.1016/S2213-2600(14)70008-624717623
- Global Initiative for Chronic Obstructive Lung Disease; 2018 www.goldcopd.org. Accessed 529, 2019.
- Clinical Practice Research Datalink (CPRD). 2019 Available from: https://www.cprd.com/. Accessed 422, 2019.
- QuintJK, MullerovaH, DiSantostefanoRL, et al. Validation of chronic obstructive pulmonary disease recording in the clinical practice research datalink (CPRD-GOLD). BMJ Open. 2014;4(7):e005540. doi:10.1136/bmjopen-2014-005540
- NHS Digital. Hospital episode statistics (HES); 2019 Available from: https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/hospital-episode-statistics#summary. Accessed 711, 2019.
- RothnieKJ, MüllerováH, HurstJR, et al. Validation of the recording of acute exacerbations of COPD in UK primary care electronic healthcare records. PLoS One. 2016;11(3):e0151357. doi:10.1371/journal.pone.015135726959820
- The National Institute for Health and Care Excellence (NICE). British national formulary; 2019 Available from: https://www.nice.org.uk/bnf-uk-only/. Accessed 816, 2019.
- HalpinDMG, de JongHJI, CarterV, SkinnerD, PriceD. Distribution, temporal stability and appropriateness of therapy of patients with COPD in the UK in relation to GOLD 2019. EClinicalMedicine. 2019;14:32–41.31709400
- LarssonK, JansonC, StällbergB, et al. Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study. Int J Chron Obstruct Pulmon Dis. 2019;14:995–1008. doi:10.2147/COPD.S19538231190785
- BrusselleG, PriceD, Gruffydd-JonesK, et al. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. Int J Chron Obstruct Pulmon Dis. 2015;10:2207–2217.26527869